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To determine whether viruses or mycoplasma have either an inductive or pro- 
vocative effect on the pathogenesis of the human leukemia, it is first necessary t o  
isolate candidate agents. Next, the agents isolated must be characterized to  deter- 
mine whether they are known human viruses or  mycoplasma. Finally, evidence 
must be accumulated to indicate whether the isolated agents can be implicated 
in the cause or pathogenesis of human leukemia. Although our  long term studies' 
have provided a number of interesting findings concerning the isolation of viruses 
from bone marrow specimens obtained from leukemic and nonleukemic patients, 
this report will summarize results on the isolation and characterization of myco- 
plasma. 
Isolation of Mycoplasma 
that it is possible to  isolate mycoplasma from 
bone marrow specimens from leukemic patients by cell culture technique when 
direct cultural methods yielded negative results. Even when cell cultures were 
used for the isolation of PPLO, it became evident (TABLE 1 )  that agents were not 
isolated frequently enough to  evaluate whether they could be implicated etio- 
logically in human leukemia. However, these experiments made it possible t o  
classify cell lines according to  their relative susceptibility to  infection (TABLE 2) 
and, consequently, to  use the sensitive cell lines to improve the isolation technique. 
Recent improvements in technique have increased the sensitivity of the assays so 
that it now appears possible to  evaluate, on the basis of isolation studies, whether 
PPLO can play a significant role in the clinical course of leukemia. The  methods 
used to  isolate mycoplasma are  outlined in TABLE 3. T h e  key points of technique 
include the use of specimens that are less than three hours old, to  make passages 
only from the positive tubes in a passage sequence, to keep the p H  of cell culture 
fluid less than 7.6, and to avoid freezing either the clinical specimen or passage 
material. Results are positive most often with specimens obtained from leukemic 
patients in relapse or who have just had the disease diagnosed. 
Representative results of the P P L O  isolation studies on bone marrow specimens 
obtained from leukemic children are presented in TABLE 4. Only children with 
leukemia in relapse or just diagnosed were studied. Isolations were done prin- 
cipally by the use of the Michigan sublines of Chang-liver and human amnion 
cells since they are most sensitive to  infection.' Representative results of isolation 
studies done on bone marrow specimens obtained from adults with leukemia are 
tabulated in TABLE 5. Often specimens from a single patient were positive simul- 
taneously in more than one cell line (TABLE 6 ) .  
Long-term studies have been carried out in an attempt to define a medium and 
procedure suitable for the direct cultivation of PPLO from bone marrow speci- 
mens.' During the period 1961-1965, more than 1000 marrow specimens were 
cultured for  PPLO. A wide variety of media and procedures were used.' Begin- 
ning in August, 1965, it has been possible to repeatedly isolate mycoplasma from 
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Previous studies 
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TABLE 1 
RECOVERY OF AGENTS: 1961-1966 
.-  
Normal Lympho-or-myelo- proliferative diseases Patient group Leukemic 
Children 40/226 = 18% 1/21 = 26% 2/13 = 15% 
Adults 12/40 = 30% 2/41 = 4% 0/2 = 0% 
. _ _  
TABLE 2 
DIFFERENTIAL SUSCEPTIBILITY OF CELL LINES TO INFECTION 
BY BONE MARROW AGENTS 
Very Sensitive Partially Sensitive Resistant 
Chang-liver HeLa (Gey) 
Human amnion HeLa 6 3 )  
Human embryonic lung Detroit-6 
Rhesus monkey kidney 
Cynomolgus monkey kidney 
Mouse fibroblasts 
Human embryonic kidney Dog kidney Chimpanzee liver cells 
Green monkey kidney Patas monkey kidney HeLa (CaS) 
TABLE 3 
METHOD FOR ISOLATION F MYCOPI ASMA 
Bone Marrow 
Heoarin 
0.1 ml + 3.9 ml BSS 
1 o.l ml 
Each of 5 Culture Tuba 
per CeU Line 
1 
Incubate at 37 For 7 Days 
c 
Centrifuge 
Fraction Fraction Fraction 




Serially Pass 6 Timer 
c 
1(\ 
CPE Positive Isolate 
PPLO Culture Cell Direct A ~ a r  Passin Pass in 
Culture Plating Plates Broth Cell CUllUre 
v CPE 
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Tneie 4 
ISOLATION OF AGENTS FROM LEUKEMIC CHILDREN 
Agents recovered from bone marrow specimen: 
None Unidentified* ViNSC8 Mycoplama 
6/13 4/13 1/13 2/13 
* Most of the unidentified agents appear to be PPLO. The virus isolated was advenovirus. 
type 12. Both specimens that yielded PPLO in cell culture also were positive when plated 
directly on agar. 
TABLE 5 
ISOLATION OF AGENTS FROM LEUKEMIC ADULTS 
Agents recovered from bone marrow specimens: 
None Unidentified* Vfruses Mycoplama 
0/10 4/10 1/10 5/10+ 
* Three specimens yielded PPLO on direct plating. The virus isolated was herpes. Most 
of the unidentified agents appear to be mycoplasma. 
TABLE 6 
SIMULTANEOUS RECOVERY OF PPLO IN MULTIPLE CELL LINES 
Leukemic bone Mycoplams isolated in: 
marrow specimen Chmg Amnion HeLaS3 Detroit4 Hep2 
2135 + + + + + 
286 + + 
El68 + + 




MEDIUM USED FOR DIRECT CULTIVATION OF PPLO 
Solid Medium 
Difco PPLO agar 
Difco Brain-Heart Infusion 
without agar 










3.0 ml block transfer technique 
20.0 ml 
10.0 ml 
Final pH 7.4 to 7.6; 5% C02-95% 
N,, 37'C; water saturated gas phase. 
Subculture positive or suspicious 
plates weekly for three weeks by agar 
Each 100 ml contained I-arginine HCL, 2.1 g; 1-glutamine, 3.0 g; Eagle 1 0 0 ~  basal vita- 
min solution, 10 ml; dextrose 5.0 g; and distilled water.' Fresh human serum was inactivated 
at  56°C for 30 min before use. Fresh yeast extract was prepared as described by Hayflick el al.' 
Broth medium contained Difco PPLO broth in place of Difco PPLO agar. 
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DIRECT ISOLATION OF MYCOPLASMA FROM BONE MARROW SPECIMENS 
Source of Type of Specimens. PPLO isolated on 
specimen leukemia positive Plates Broth 
Children ASL 13 1 12 
AGL; AMML+ 4 3 1 
Adults 
CLL, HML 
* Total number positive to date. 
+ ASL-Acute stem-cell leukemia; AMML-Acute myelomonocytic leukemia; AGL-Acute 
granulocytic leukemia; CLL-Chronic lymphocytic leukemia; HML-Histiomonocytic leuke- 
mia. 
FIGURE 1. When bone marrow specimens were plated, often colonies were observed that 
appeared to be PPLO. They could not be propagated on artificial medium. Frequently they 
could be grown if transferred to susceptible cell cultures (see TABLE 3) and passed serially. 
fresh marrow specimens by use of the media described in TABLE 7. The specimens 
that have yielded PPLO to date are listed in TABLE 8. Many specimens yielded 
abortive colonies that could not be serially propagated (FIGURE 1 ). 
Some guidelines evolved from these studies. First, it appears that PPLO can be 
isolated regularly from bone marrow specimens obtained from leukemic patients. 
Our results suggest that, under ideal conditions, patients with leukemia in relapse 
or with initially diagnosed disease most frequently yield PPLO. Perhaps 0.1 to 
1.0% of normal persons have transient or latent PPLO infection. It is particularly 
clear that the PPLO isolated are extraordinarily fastidious in their requirements 
for growth in vitro. 
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Serologic Analysis of  Isolated Mycoplasma 
Because of pitfall~l*~-' inherent in the use of cell cultures for the isolation of 
PPLO, it was essential to determine whether the mycoplasma isolated were known 
strains. It also was necessary to antigenically group the isolated mycoplasma to 
carry out comparative antibody studies on leukemic and nonleukemic patients. 
Fermentation and Clyde tests, carried out to make a preliminary identification of 
the isolated mycoplasma, disclosed that many of them were related to M .  fer- 
mentans. The results of such pilot studies provided the basis for an analysis of 
their antigenic relationships. Cloned lines of PPLO grown in rabbit serum medium 
were used to immunize rabbits.* 
Because the PPLO isolated were cytopathic, it was possible to compare them 
according to the effect of antisera on their cytopathic effect in cell culture (CPE 
neutralization tests) and, at the same time, measure the inhibition of growth in 
terms of colony-forming units (CFU inhibition tests). Antiserum, (0.1 ml) and 
PPLO (100 TCID5,,-Tissue Culture Infectious Doses) was added to each of five 
culture tubes per test. Control cultures received either PPLO alone, PPLO plus 
homotypic antiserum, or immune serum alone. Cultures were incubated at 37" C 
for seven days and the pH adjusted to 7.4 by addition of bicarbonate on alternate 
days. CPE was scored 1+  to 4+; 4+ designated complete cell destruction. CPE 
was scored daily. At the end of seven days, culture fluids were pooled and plate 
counts made. Experiments were repeated three to five times. On the basis of such 
tests (TABLES 9 and lo) ,  it was possible to classify the mycoplasma as identical, 
related, or different. 
TABLE 9 
CPE NEUTRALIZATION TESTS WITH CHANG-LIVER CELLS 
Mycoplama CPE in cultures containing anti-K10 serum 
Degree of inhibition 
of CPE. 
K10 1-2+ >15% 
K1 None 100% 
262 3-4+ 0% 
* Strains were scored identical if CPE was inhibited by 50% or more, related if inhibition 
was less than 50%, and diflerent if CPE was not inhibited. K10 = PPLO from undifferen- 
tiated sarcoma with bone metastases; K1 = PPLO from acute granulocytic leukemia; and 
262 = PPLO from acute myelomonocytic leukemia. 
TABLE 10 
GROWTH (CFU) INHIBITION TESTS WITH CHANG-LIVER CELLS 
Mycoplasma Inhibition of growth. in cultures containing anti-K10 =rum 
K10 6 logs 
K1 4 logs 
262 0 logs 
* Growth in control cultures containing normal rabbit serum usually reached a density of 
107 to 108 CFU/ml. Strains were scored identical if growth was reduced 5-8 logs, related for 
3-4 logs, and diflerent if reduction was two logs or less. Experiments usually were repeated 
two to four times. 
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Floune 2. Mycoplasma strain F3 was spread over the agar surface. Antisera to the indi- 
cated strains (MF = M .  fermentam) were tested against strain F3. Control tcsts with homo- 
typic antisera were done in parallel. The results illustrate that strain 262 was diflerent from F3. 
TABLE 11 
CLASSIPICATION OF MYCOPLASMA BY THE CLYDE GROWTH 
INHIBITION TEST 
Inhibition: Diameter In MM 
Confluent 100-500 10-100 
Degree of* 
inhibition Mycoplasma 
K10 6 10 100% 
K1 15 20 20 200% 
262 0 4 I <SO% 
* Strains were scored identical if the zone of inhibition at the 100 to 500 dose of inoculum 
was 5-15 MM, related if less than 5 MM, and diflerent if there was no inhibition of growth. 
Anti-K10 serum was used for tests. 
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A study of the Clyde technique revealed that an inoculum that gave from 100 
to 500 colonies per plate gave results that were accurate and the most sensitive 
(FIGURE 2). From the representative results presented in TABLE 1 1,  it was possible 
to classify the bone marrow PPLO as identical, related or diflerent. 
In general, the procedures described by Taylor-Robinson et aLS were used for 
complement-fixation (CF) tests. Most of the strains of PPLO tested were not 
TABLE 12 
CLASSIFICATION OF MYCOPLASMA BY COMPLEMENT-FIXATION ESTS 




K10 800 I 
K1 800 I 
F21 100 D 
Strains were scored either identical or different by the CF test. Strains were scored dif- 
ferent only if their titer was three tubes different from control. 
TABLE 13 
CLASSIFICATION OF MYCOPLASMA BY THE INDIRECT 
HEM AGGLUTINATION TEST 
Mycoplama Reciprocal of IHA Titer with ~ t i - K l O  serum 
Relatiomhip of 
Strains. 
K10 500 Identical 
K1 200 Identical 
F21 100 DifTerent 
*Strains were scored different only if the IHA titer was two tubes greater or less than 
control, F21 was isolated from a child with acute stem-cell leukemia. 
TABLE 14 
ANTIGENIC RELATIONSHIP OF MYCOPLASMA TO GDL STRAIN 
Results of tests with anti-GDL serum: Mycoplama Isolated from 
atrain patient with CFLJ CLYDE CP IHA 
~~ 
GDL* I I I I 
~~ 
F7 ES D D D I 
262 AMML D D D I 
286 AGL D D D 
263 CLL D D D D 
* GDL = Contaminant of human embryonic lung cells.' 
ASL = Acute stem cell leukemia. 
AMML = Acute myelomonocytic leukemia. 
AGL = Acute granulocytic leukemia. 
CLL = Chronic lymphocytic leukemia. 
ES = Ewing sarcoma. 
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ANTIGENIC DIFFERENCES IN THE MYCOPLASMA ISOLATED FROM 
BONE MARROW SPECIMENS 
Antiserum Prepared Againat: 
M.ferrnenruns I* I I I 
263 I I D I  
R t  I I I DS R I I 
I I I D R  1 I 1  
K1 I I I 1  
F21 D D I D  
D I I 1  D D I D  
D D D D D  D D D  
anticomplementary. Strains were scored as either identical or different when 
tested against a single antiserum (TABLE 12). 
When the representative strains of mycoplasma were compared* by use of 
the indirect hemagglutination technique (IHA) , it also was possible to  classify 
them as identical or diflerent (TABLE 13). 
A number of serologically distinct PPLO have been isolated from cell lines7- 
viz., strains Fll ,  F12, T7 and GDL. Results of tests with anti-GDL sera (TABLE 
14) showed that our strains were different from the GDL group. In TABLE 14, the 
term F designates a bone marrow specimen used by us for isolation studies.' 
A comparison of the results (TABLE 15) obtained for the representative myco- 
plasma provided a basis for a number of generalizations: The CFU growth- 
inhibition test was more reliable than the CPE neutralization technique and more 
sensitive than the Clyde test. The results of the Clyde and other growth-inhibition 
tests agreed in general. The CF and IHA tests gave results that were not related 
to each other or t o  the growth-inhibition tests. The isolated mycoplasma com- 
prised three distinct groups. One group was very similar to M .  fermentam: 
for convenience, members of the group were scored identical (I = identical). 
The second group included strains that were either closely or distantly related 
(R = related) to M .  fermentans. The third group was different from M .  fer- 
mentans (D = different). Antiserum to M .  fermentans failed to distinguish 
among the groups because M .  fermentans appears to have antigens in common 
with organisms in all three groups. By the use of appropriate antisera, it is possible 
to further subdivide each of the major groups. Thus, like the Salmonella and 
Shigella, each species of mycoplasma can be expected to encompass a mosaic of 
antigens that differ from each other to various degrees. Major methodological 
problems exist in arriving at a serologic analysis of mycoplasma strains.9 
Induction of Leukemoid Disease in Mice by Isolated Mycoplasma 
To further characterize the strains of mycoplasma isolated, they were cloned, 
grown in medium containing horse serum, centrifuged (15,000 X G-30 min), 
resuspended in growth medium to a concentration of approximately lo8 CFU 
(colony-forming units) per ml, and injected IP (intraperitoneally) into 3 4  
weeks-old BALB female mice. In from two to eight weeks, mice developed a 
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F i o m  3. Mouse with fatal leukemoid disease. Note enlarged spleen, anillary and in- 
guinal nodes, mesenteric nodes (arrow), and thymus. 
leukemoid disease’”B8 that was either chronic or acute. The gross pathology of 
the disease simulated transplanted or spontaneous virus leukemia (FIGURE 3). 
The peripheral white blood count in mice with leukemoid disease ranged from 
three to ten times normal, and was characterized by a marked increase in seg- 
mented neutrophiles. The spleen, liver, inguinal and axillary nodes were moder- 
ately to greatly enlarged. The microscopic pathology was characterized by a 
marked follicular hyperplasia of the spleen and nodes. In chronic disease, the 
initial follicular hyperplasia involving the spleen was followed by a progressive 
loss in its architecture (FIGURE 4). Bone marrow, like the spleen and lymph 
nodes, was very hyperplastic with a predominance of mature-appearing seg- 
mented neutrophiles (FIGURE 5 ) .  However, there was no infiltration of malignant 
cells into organs that was characteristic of leukemia. Anemia occurred in diseased 
mice but was not prominent. Mice with leukemoid disease had their growth 
stunted and were ill throughout their life. The mycoplasma injected could be 
isolated from mice with leukemoid disease, particularly if they were treated with 
cortisone. 
When the dose of mycoplasma injected IP was log CFU/ml or greater, mice 
died in from 24-48 hours (TABLE 16). No signs of CNS disease were observed 
that resembled those caused by the toxin of M. neurolyticum. Various inbred 
strains of mice were susceptible to infection. The injected mycoplasma could be 
recovered from mice in pure culture and were identified by serologic and other 
tests as the PPLO injected originally. 
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When the bone marrow strains of mycoplasma ( lo8 CFU per ml) were injected 
IV (intravenously-1.0 mllmouse), mice died in from two to five minutes. The 
mycoplasma when injected IV also killed rabbits within 24-48 hours. When strains 
of M .  fermentans, M .  hominis, types 1 and 2. M .  orale, M .  salivarium, or M .  
pneumoniae were grown and injected into mice by the methods used for the bone 
marrow strains of PPLO, they were essentially nonpathogenic. Filtrates of the 
broth in which the bone marrow PPLO were grown likewise were not pathogenic 
when tested throughout the growth cycle of the organisms. 
Antibody Studies 
To learn whether the mycoplasma isolated could be implicated in the patho- 
genesis of leukemia, serum neutralization tests were done. Mycoplasma represen- 
tative of those isolated from children were used. Sera usually were tested 0 to two 
days after they were drawn. Pilot studies disclosed’ that most sera lost their 
neutralizing activity when stored at either -20 or -70 C. Sera diluted 1 : l O  in 
Hanks solution10 were added (0.1 ml) to each of five culture tubes per test. 
Each test strain of PPLO was used at a dose of 100 TCID,,. Cultures were in- 
cubated at 37” C for seven days and CPE-scored as noted above. The results 
(TABLE 17) of the neutralization tests revealed that neutralizing “antibody” to 
mycoplasma strain F3 was present two to three times more frequently in sera 
- 
FIGURE 4. Spleens from mice with leukemoid disease showed a marked foll idar hyper- 
plasia: Normal mouse spleen (A); spleen from a mouse with acute leukemoid disease (B); 
spleen from mouse moribund from chronic leukemoid disease ( C ) .  In (C) note the loss in 
architecture. (Magnification 35 X ; hematoxylia-eosin stain). 
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FIOURE 5. Hyperplastic changes in the spleen (A) and bone marrow (B). Note the 
marked mepakaryocytosh and granulopoiesis. (Magnification 432X; hematoxylin-cosin stain). 
TABLE 16
LETHALITY OF MYCOPLASMA FOR MICE 
K1 Acute granulocytic leukemia 109 to 1010 22/22 
K7 Acute stem-cell leukemia 18/18 . 
K10 Undifferentiated sarcoma 
with bone metastases 
I' 46/51 
'6 F3 Disseminated lupus erythematosus 31/33 
* Composite results from three or more replicate experiments. 
obtained from leukemic patients than in controls. A correlative pattern existed 
between the neutralizing effect of sera from leukemic ,children and mycoplasma 
strain K7, isolated from a child with acute stem cell leukemia. Leukemic children 
also more frequently had antibody to mycoplasma strain K10. 
Because a correlation appeared to exist between leukemia in children and 
mycoplasma K7, control experiments were done to test whether leukemic patients 
had a normal pattern of antibody distribution to common known viruses.' Both 
leukemic children and adults (TABLE 18) less frequently had antibodies to polio 
and vaccinia virus than normal children. Leukemic adults twice as frequently 
had antibody to adenovirus type 4 compared to normal controls. The results of 
these studies suggest that a pattern of antibody distribution which appears to 
relate leukemia to a given virus or mycoplasma infection may be misleading. Since 
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SERUM NEUTRALIZATION TESTS ON MYCOPLASMA 
ISOLATED FROM BONE MARROW SPECIMENS 
Proportion of Sera That Neutralized: 
Kl K7 K10 F3 t 
Serum Group 
Normal adults* 5/53 5/53 8/53 0/53 
Leukemic adultst 3/54 0/52 0/54 17/54 
Normal children 5/39 0/39 2/39 4/39 
Leukemic children 3/39 15/39 7/39 8/39 
* Combined serum specimens from 15 to 20 pints of blood. All antibody titrations were 
repeated 3 to 5 times. 
t All types of leukemia or lymphoma are grouped in this category. Mycoplasma strain F3 
was neutralized by 45% (9/20) of serum specimens obtained from adults with lymphocytic 
leukemia. 
t K1 = Acute granulocytic leukemia; K7 = Acute stem cell leukemia; K10 = UndifTerenti- 
ated sarcoma with bone metastases. 
TABLE 18
NEUTRALIZATION OF KNOWN VIRUSES BY SERA FROM LEUKEMIC 
AND NONLEUKEMIC PATIENTS 
Proportion of Sera That Neutralized: 
Serum Group 
Poliovirus Vaccinia Herpes- Adenovirus Adcnovims 
type 2 virus virus type 4 type 12 
Normal adults 28/40 24/40 19/40 5/20 8/40 
Leukemic adults 2 1 /40 20/40 16/40 11/20 6/41 
Normal children 33/40 28/40 9/40 5/34 8/40 
Leukemic children 28/41 21/41 13/41 3/27 8/41 
leukemia markedly affects the reticulo-endothelial system, it is reasonable to 
assume that it may manifest itself in a variety of ways, including unusual antibody 
patterns.” 
Discussion and Summary 
Mycoplasma were isolated regularly by cell culture techniques from bone 
marrow specimens of leukemic patients. Mycloplasma also were isolated directly 
on agar plates but with a very low (0.1 %) frequency. Mycoplasma were isolated 
most frequently from adults with leukemia. Specimens obtained from patients 
with leukemia in relapse, or who just had the disease diagnosed, most often 
were positive. 
An antigenic analysis of the isolated mycoplasma disclosed that they comprised 
three subgroups. Two subgroups shared common antigens and were either closely 
or distantly related to M. ferrnentans. The third subgroup was very different 
antigenically from M. fermentans but also has some antigens in common with it. 
The isolated mycoplasma induce a granulocytic leukemoid disease in mice 
that resembles a syndrome in man12 called “Familial Myeloproliferative Disease.” 
High concentrations of PPLO killed mice or rabbits in 24-48 hours. 
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The results of antibody studies in leukemic and nonleukemic patients, in con- 
junction with the isolation and mouse pathogenicity experiments, suggest that 
mycoplasma cause latent infection in both normal and leukemic patients. In 
leukemic patients, particularly adults, active mycoplasma infection may depend 
on the stage of disease. Mycoplasma infection presumably becomes active in 
patients with leukemia because of decreased host resistance during progression 
of the disease. 
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